Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma
This study has been completed.
Study NCT00044863   Information provided by ImClone LLC

First Received on September 5, 2002.   Last Updated on February 21, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Neoplasms
Metastases, Neoplasm
Additional conditions recognized in this trial
Carcinoma
Neoplasm Metastasis
Neoplasms
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplastic Processes
Pathologic Processes
Rectal Diseases
Interventions listed in this trial
Erbitux (Cetuximab)
Additional drug interventions recognized in this trial
Cetuximab
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
ImClone LLC


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services